Table 4.
Time spent in each health state
| Health state | Time spent in each health state, years |
|
|---|---|---|
| Exemestane | Tamoxifen | |
| No recurrence | 12.124 | 12.309 |
| No recurrence with osteoporosis | 2.243 | 1.343 |
| Total time in no recurrence | 14.367 | 13.652 |
| Local recurrence | 0.032 | 0.037 |
| Local recurrence with osteoporosis | 0.006 | 0.004 |
| Total time in local recurrence | 0.038 | 0.041 |
| Contra-lateral disease | 0.020 | 0.024 |
| Contra-lateral disease with osteoporosis | 0.004 | 0.002 |
| Total time in contra-lateral disease | 0.024 | 0.026 |
| Distant recurrence | 0.217 | 0.240 |
| Distant recurrence with osteoporosis | 0.039 | 0.025 |
| Total time in distant recurrence | 0.256 | 0.265 |
| Remission | 0.616 | 0.728 |
| Remission with osteoporosis | 0.112 | 0.073 |
| Total time in remission | 0.728 | 0.801 |
| Endometrial cancer | 0.025 | 0.036 |
| Post-thromboembolism | 0.152 | 0.355 |
| Death | 22.413 | 22.838 |